R. Lambert-Falls

776 total citations
9 papers, 578 citations indexed

About

R. Lambert-Falls is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, R. Lambert-Falls has authored 9 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 3 papers in Dermatology. Recurrent topics in R. Lambert-Falls's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (3 papers). R. Lambert-Falls is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (3 papers). R. Lambert-Falls collaborates with scholars based in United States, Switzerland and Germany. R. Lambert-Falls's co-authors include Rebecca Gelman, Eric P. Winer, Harold J. Burstein, P. Kelly Marcom, Aparna Keshaviah, Ronald D. Hart, Ari David Baron, Nigel Bundred, Adam Brufsky and Raul Mena and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

R. Lambert-Falls

9 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lambert-Falls United States 6 544 261 102 98 61 9 578
Walid Basher Israel 7 268 0.5× 133 0.5× 90 0.9× 57 0.6× 7 0.1× 9 446
Rochelle Strenger United States 6 370 0.7× 131 0.5× 164 1.6× 60 0.6× 2 0.0× 19 414
Ines Figueiredo United Kingdom 11 237 0.4× 93 0.4× 232 2.3× 356 3.6× 7 0.1× 26 576
Charles R. Sikes United States 10 175 0.3× 84 0.3× 72 0.7× 262 2.7× 13 0.2× 12 402
Yoshimasa Miyagawa Japan 14 299 0.5× 87 0.3× 183 1.8× 77 0.8× 2 0.0× 29 431
Elisabeth Bergen Austria 12 303 0.6× 45 0.2× 67 0.7× 207 2.1× 2 0.0× 41 413
Charlotte Hodgkin United Kingdom 4 112 0.2× 121 0.5× 263 2.6× 136 1.4× 5 0.1× 5 421
Jean-Yves Leroy Belgium 6 396 0.7× 104 0.4× 158 1.5× 49 0.5× 11 465
Francis M. Senecal United States 6 308 0.6× 25 0.1× 253 2.5× 72 0.7× 3 0.0× 14 431
S. Kahlert Germany 6 445 0.8× 132 0.5× 299 2.9× 138 1.4× 12 539

Countries citing papers authored by R. Lambert-Falls

Since Specialization
Citations

This map shows the geographic impact of R. Lambert-Falls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lambert-Falls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lambert-Falls more than expected).

Fields of papers citing papers by R. Lambert-Falls

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lambert-Falls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lambert-Falls. The network helps show where R. Lambert-Falls may publish in the future.

Co-authorship network of co-authors of R. Lambert-Falls

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lambert-Falls. A scholar is included among the top collaborators of R. Lambert-Falls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lambert-Falls. R. Lambert-Falls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Brufsky, Adam, Nigel Bundred, Robert E. Coleman, et al.. (2008). Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole. The Oncologist. 13(5). 503–514. 134 indexed citations
3.
Burstein, Harold J., Aparna Keshaviah, Ari David Baron, et al.. (2007). Trastuzumab plus vinorelbine or taxane chemotherapy for HER2‐overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study. Cancer. 110(5). 965–972. 152 indexed citations
4.
Lambert-Falls, R., et al.. (2007). Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study. Clinical Breast Cancer. 7(9). 697–704. 8 indexed citations
5.
6.
Burstein, HJ, Aparna Keshaviah, Ronald D. Hart, et al.. (2006). Trastuzumab and vinorelbine or taxane chemotherapy for HER2+ metastatic breast cancer: The TRAVIOTA study. Journal of Clinical Oncology. 24(18_suppl). 650–650. 9 indexed citations
7.
Lambert-Falls, R., et al.. (2006). Phase III adjuvant trial of concurrent epirubicin/taxane vs. sequential epirubicin/cyclophosphamide followed by taxane for node positive breast cancer. Journal of Clinical Oncology. 24(18_suppl). 573–573. 2 indexed citations
8.
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walid Basher Breakdown of academic impact, for papers by Rochelle Strenger Breakdown of academic impact, for papers by Ines Figueiredo Breakdown of academic impact, for papers by Charles R. Sikes Breakdown of academic impact, for papers by Yoshimasa Miyagawa Breakdown of academic impact, for papers by Elisabeth Bergen Breakdown of academic impact, for papers by Charlotte Hodgkin Breakdown of academic impact, for papers by Jean-Yves Leroy Breakdown of academic impact, for papers by Francis M. Senecal Breakdown of academic impact, for papers by S. Kahlert
Rankless by CCL
2026